EE3 Cost-Utility Analysis of Xelox Plus Bevacizumab Versus Xelox for Metastatic Colorectal Cancer Treatment in Thailand

EE3 Cost-Utility Analysis of Xelox Plus Bevacizumab Versus Xelox for Metastatic Colorectal Cancer Treatment in Thailand

Saved in:
Bibliographic Details
Published in:Value in health Vol. 25; no. 12; p. S53
Main Authors: Wanitphisitphan, C, Kositamongkol, C, Korphaisarn, K, Akewanlop, C, Srimuninnimit, V, Phisalprapa, P
Format: Journal Article
Language:English
Published: Elsevier Inc 01-12-2022
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:1098-3015
1524-4733
DOI:10.1016/j.jval.2022.09.258